Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pashna N. Munshi"'
Autor:
Omar Davila, Muzaffar H. Qazilbash, Parameswaran Hari, Nina Shah, Pashna N. Munshi, Shaji Kumar, David H. Vesole, Andrew St. Martin, Anita D'Souza
Publikováno v:
Cancer, vol 127, iss 22
BACKGROUND Consolidative autologous hematopoietic stem cell transplantation (AHCT) is commonly used for patients with multiple myeloma (MM). We studied AHCT use and outcomes in patients with MM ≥75 years old. METHODS Patients with MM ≥75 years ol
Autor:
Pashna N. Munshi, Yue Chen, Kwang W. Ahn, Farrukh T. Awan, Amanda Cashen, Geoffrey Shouse, Mazyar Shadman, Paul Shaughnessy, Joanna Zurko, Frederick L. Locke, Aaron M. Goodman, Jose C. Villaboas Bisneto, Craig Sauter, Mohamad A. Kharfan-Dabaja, Gabrielle Meyers, Samantha Jaglowski, Alex Herrera, Mehdi Hamadani
Publikováno v:
Transplantation and cellular therapy. 28(8)
Data for outcomes after autologous hematopoietic cell transplantation (auto-HCT) in diffuse large B-cell lymphoma (DLBCL) patients ≥70 years are limited. Auto-HCT is feasible in older DLBCL patients. Using the Center for International Blood and Mar
Autor:
Kwang Woo Ahn, Mohamed A. Kharfan-Dabaja, Nirav N. Shah, Farhad Khimani, Praveen Ramakrishnan Geethakumari, Sairah Ahmed, Yue Chen, Sachiko Seo, Nilanjan Ghosh, Narendranath Epperla, Mehdi Hamadani, Sanghee Hong, Amer Beitinjaneh, Pashna N. Munshi, Tim Prestidge, Leona Holmberg, Victor A. Chow, Michael Scordo, Yago Nieto, Natalie S Grover, Umar Farooq, Nada Hamad, Reem Karmali, Gerhard C. Hildebrandt, Andrew R. Rezvani, Jean A. Yared, Antonio Jimenez-Jimenez, Maxwell M. Krem, Bhagirathbhai Dholaria, Evgeny Klyuchnikov, Craig S. Sauter, David J. Inwards, Peter A. Riedell, Trent P Wang, Farrukh T. Awan, Alex F. Herrera, Andy I. Chen, Melhem Solh, Vaishalee P. Kenkre
Publikováno v:
JAMA Oncol
IMPORTANCE: Primary central nervous system lymphoma (PCNSL) requires induction and consolidation to achieve potential cure. High-dose therapy and autologous hematopoietic cell transplant (AHCT) is an accepted and effective consolidation strategy for
Autor:
Ambuj Kumar, Anna Sureda, Jonathon B. Cohen, Veronika Bachanova, Kami J. Maddocks, Jonathan W. Friedberg, Mehdi Hamadani, Sonali M. Smith, Sairah Ahmed, John P. Leonard, Brad S. Kahl, Craig S. Sauter, Timothy S. Fenske, Frederick L. Locke, Carmello Carlo-Stella, Brian T. Hill, Mohamed A. Kharfan-Dabaja, Amanda F. Cashen, Mazyar Shadman, Michael Wang, Mahmoud Aljurf, Tycel Phillips, Pashna N. Munshi, Alex F. Herrera, Bipin N. Savani, Nilanjan Ghosh, David J. Inwards, Mats Jerkeman, Martin Dreyling, Vaishalee P. Kenkre, Matthew A. Lunning, Peter Dreger, Stephen P. Robinson, Manali Kamdar
Publikováno v:
Bone marrow transplantation. 56(12)
Autologous (auto-) or allogeneic (allo-) hematopoietic cell transplantation (HCT) are accepted treatment modalities for mantle cell lymphoma (MCL). Recently, chimeric antigen receptor (CAR) T-cell therapy received approval for MCL; however, its exact
Autor:
Hemant S. Murthy, Kwang Woo Ahn, Noel Estrada-Merly, Hassan B. Alkhateeb, Susan Bal, Mohamed A. Kharfan-Dabaja, Bhagirathbhai Dholaria, Francine Foss, Lohith Gowda, Deepa Jagadeesh, Craig Sauter, Muhammad Bilal Abid, Mahmoud Aljurf, Farrukh T. Awan, Ulrike Bacher, Sherif M. Badawy, Minoo Battiwalla, Chris Bredeson, Jan Cerny, Saurabh Chhabra, Abhinav Deol, Miguel Angel Diaz, Nosha Farhadfar, César Freytes, James Gajewski, Manish J. Gandhi, Siddhartha Ganguly, Michael R. Grunwald, Joerg Halter, Shahrukh Hashmi, Gerhard C. Hildebrandt, Yoshihiro Inamoto, Antonio Martin Jimenez-Jimenez, Matt Kalaycio, Rammurti Kamble, Maxwell M. Krem, Hillard M. Lazarus, Aleksandr Lazaryan, Joseph Maakaron, Pashna N. Munshi, Reinhold Munker, Aziz Nazha, Taiga Nishihori, Olalekan O. Oluwole, Guillermo Ortí, Dorothy C. Pan, Sagar S. Patel, Attaphol Pawarode, David Rizzieri, Nakhle S. Saba, Bipin Savani, Sachiko Seo, Celalettin Ustun, Marjolein van der Poel, Leo F. Verdonck, John L. Wagner, Baldeep Wirk, Betul Oran, Ryotaro Nakamura, Bart Scott, Wael Saber
Publikováno v:
Murthy, Hemant S; Ahn, Kwang Woo; Estrada-Merly, Noel; Alkhateeb, Hassan B; Bal, Susan; Kharfan-Dabaja, Mohamed A; Dholaria, Bhagirathbhai; Foss, Francine; Gowda, Lohith; Jagadeesh, Deepa; Sauter, Craig; Abid, Muhammad Bilal; Aljurf, Mahmoud; Awan, Farrukh T; Bacher, Ulrike; Badawy, Sherif M; Battiwalla, Minoo; Bredeson, Chris; Cerny, Jan; Chhabra, Saurabh; ... (2022). Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research. Transplantation and cellular therapy, 28(4), 187.e1-187.e10. Elsevier 10.1016/j.jtct.2022.01.017
Transplant Cell Ther
Transplantation and Cellular Therapy, 28(4), 187.e1-187.e10. Elsevier
Transplant Cell Ther
Transplantation and Cellular Therapy, 28(4), 187.e1-187.e10. Elsevier
T cell prolymphocytic leukemia (T-PLL) is a rare, aggressive malignancy with limited treatment options and poor long-term survival. Previous studies of allogeneic hematopoietic cell transplantation (alloHCT) for T-PLL are limited by small numbers, an
Autor:
Kwang Woo Ahn, Baldeep Wirk, Miguel-Angel Perales, Alex F. Herrera, Hemant S. Murthy, Javier Bolaños-Meade, Pashna N. Munshi, Rodrigo Martino, Abraham S. Kanate, Nasheed Hossain, Ana Sureda, Yago Nieto, Umar Farooq, Nilanjan Ghosh, Vera Ulrike Bacher, Nelli Bejanyan, Sairah Ahmed, Jennifer A. Kanakry, Timothy S. Fenske, Hisham Abdel-Azim, Alberto Mussetti, Sachiko Seo, Mahmoud Aljurf, David J. Inwards, Rizwan Romee, Jonathon B. Cohen, Jean A. Yared, Carlos Litovich, Mehdi Hamadani, Ephraim J. Fuchs, Bipin N. Savani
Publikováno v:
Biol Blood Marrow Transplant
Classic Hodgkin lymphoma (cHL) patients with relapsed or refractory disease may benefit from allogeneic hematopoietic cell transplantation (allo-HCT), but many lack a matched sibling donor (MSD). Herein, we compare outcomes of 2 reduced-intensity con